← Back to Search

Other

Non-invasive Nerve Stimulation for PTSD

N/A
Recruiting
Led By John Williamson, Ph.D.
Research Sponsored by University of Florida
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Must not have
Breathing disorder requiring constant use of oxygen
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 8 hours
Awards & highlights

Summary

This trial is testing whether two types of nerve stimulation can change sleep architecture.

Who is the study for?
This trial is for veterans who have PTSD, with or without a history of mild traumatic brain injury (TBI). It's not open to those with severe psychiatric illnesses not related to PTSD/TBI, significant medical conditions affecting cognition, or current drug abuse issues.Check my eligibility
What is being tested?
The study is testing two different locations of transcutaneous nerve stimulation to see how they affect sleep patterns in individuals suffering from PTSD and/or TBI.See study design
What are the potential side effects?
While the document doesn't specify side effects, transcutaneous nerve stimulation can sometimes cause skin irritation at the site of application, discomfort during use, and muscle twitching.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I need to use oxygen all the time for my breathing problem.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 8 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 8 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Physiological sleep architectural quality

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Noninvasive nerve stimulation type IExperimental Treatment2 Interventions
This group will receive one type of nerve stimulation
Group II: Noninvasive nerve stimulation type IIActive Control2 Interventions
This group will receive second type of nerve stimulation

Find a Location

Who is running the clinical trial?

University of FloridaLead Sponsor
1,354 Previous Clinical Trials
713,125 Total Patients Enrolled
US Department of Veterans AffairsFED
871 Previous Clinical Trials
497,726 Total Patients Enrolled
North Florida/South Georgia Veterans Health SystemOTHER
7 Previous Clinical Trials
1,764 Total Patients Enrolled
~8 spots leftby Oct 2024